---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-000691"
form_type: "8-K"
ticker: "CELZ"
cik: "0001187953"
company_name: "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC."
filed_at: "2022-02-11T23:59:59+00:00"
generated_at: "2026-06-27T08:41:20.892125+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Creative Medical enters new 3-year employment agreements with CEO and CFO

## Summary
- CEO Warbington base salary $330,000/year; CFO Dickerson $300,000/year.
- Each eligible for annual cash bonus targeted at 30% of base salary.
- Annual option grant valued at 30% of base salary, vesting over 3 years (25% immediate, then annual).
- Severance: if terminated without cause or for good reason, 2 years of base salary plus bonuses.
- Employment agreements have 3-year initial term with automatic renewal for successive 3-year periods.

## SEC filing metadata
- accession: 0001477932-22-000691
- form_type: 8-K
- ticker: CELZ
- cik: 0001187953
- company_name: CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
- filed_at: 2022-02-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1187953/000147793222000691/0001477932-22-000691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1187953/000147793222000691/celz_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-000691
- JSON: https://secwatch.observer/filing/0001477932-22-000691.json
- Plain text: https://secwatch.observer/filing/0001477932-22-000691.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.